University Hospital of Salamanca
Salamanca, Spain
University hospital in Salamanca
P.º de San Vicente, 182, 37007 Salamanca
About University Hospital of Salamanca
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at University Hospital of Salamanca
During the past decade, University Hospital of Salamanca conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 4 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Plasma Glucose Levels With Dexamethasone as Adjuvant to Interscalene Block
2012-11-01
2013-11-01
Withdrawn
0
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
2014-08-18
2026-10-10
Active, not recruiting
450
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
2014-08-18
2036-05-01
Recruiting
168
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
2015-08-12
2025-12-31
Active, not recruiting
6,452
High-Dose Recombinant Interferon Alfa-2B, Ipilimumab, or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
2015-10-15
Active, not recruiting
1,378
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
2016-12-08
2023-02-15
Terminated
3,021
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University Hospital of Salamanca" #1 sponsor was "Red de Terapia Celular" with 2 trials, followed by "AORTICA Group" with 1 trials
sponsored, "Affimed GmbH" with 1 trials sponsored, "BioLineRx, Ltd." with 1 trials sponsored and "CTI BioPharma"
with 1 trials sponsored. Other sponsors include 14 different institutions and
companies that sponsored additional 24 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital of Salamanca"
#1 collaborator was "Haematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo Fernández-Roldán" with 3 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Spanish National Health System" with 2 trials as a collaborator, "Castilla y León Hematology and hemotherapy Foundation" with 1 trials as a collaborator and "European Research Council" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were
collaborators in the rest 17 trials.
Clinical Trials Conditions at University Hospital of Salamanca
According to Clinical.Site data, the most researched conditions in "University Hospital of Salamanca" are
"Multiple Myeloma" (5 trials), "Myelofibrosis" (2 trials), "Primary Myelofibrosis" (2 trials), "Acute Myeloid Leukemia" (1 trials) and "Aspergillus" (1 trials). Many other conditions were trialed in "University Hospital of Salamanca" in a lesser frequency.
Clinical Trials Intervention Types at University Hospital of Salamanca
Most popular intervention types in "University Hospital of Salamanca" are "Drug" (15 trials), "Biological" (5 trials), "Procedure" (4 trials), "Device" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Daratumumab" (2 trials), "Dexamethasone" (2 trials), "Pembrolizumab" (2 trials), "TL-895" (2 trials) and "17mm aortic valve (On-X )" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University Hospital of Salamanca
The vast majority of trials in "University Hospital of Salamanca" are
25 trials for "All" genders.
Clinical Trials Status at University Hospital of Salamanca
Currently, there are NaN active trials in "University Hospital of Salamanca".
undefined are not yet recruiting,
6 are recruiting,
5 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 10 completed trials in University Hospital of Salamanca,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in University Hospital of Salamanca, 5 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".